Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01887964 · ClinicalTrials.gov registry record · NA

Effect of Resistant Starch (Type-4) on Metabolic Syndrome

A NA study, sponsored by South Dakota State University.

Completed
Registry status
NA
Development phase
86
Enrollment target

NCT01887964 is a NA study that has completed, run by South Dakota State University. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01887964, a NA study, has completed, sponsored by South Dakota State University.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target

Study Summary

Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrome. However, due to altered taste and texture of the high fiber foods, long term intake of fiber is a challenge for metabolic syndrome patients. This study is designed to find if blinded-substitution of regular wheat flour in domestic kitchen with wheat flour enriched by an adaptable type of fiber (resistant starch-4), minimizes metabolic syndrome symptoms. this special type of fiber is also obtained from wheat.

Interventions

  • OTHER RS4 enriched flour
  • OTHER Control flour

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2012-03
Est. Completion 2012-10
Phase NA

Sponsor

South Dakota State University

11 total trials

What the Registry Record Tells You About NCT01887964

The ClinicalTrials.gov registry entry for NCT01887964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is South Dakota State University, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which RS4 enriched flour is the first listed.

NCT01887964 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01887964 about?

NCT01887964 is a clinical study titled "Effect of Resistant Starch (Type-4) on Metabolic Syndrome". Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrom...

What is the current status of trial NCT01887964?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2012-03. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01887964?

The interventions under investigation include: RS4 enriched flour (OTHER), Control flour (OTHER).

Who is sponsoring clinical trial NCT01887964?

This trial is sponsored by South Dakota State University, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.